SeaStar Medical Approves $425K Retention Bonuses for CEO and Executive
ICU has more than doubled off its 52-week low of $2.07 on elevated volume (4.6× avg).
Summary
SeaStar Medical has approved retention bonuses totaling $425,000 for CEO Eric Schlorff and another executive, comprising cash and restricted stock units, to be paid over three installments through March 2027.
Key Events · Executive and Board Changes · ICU
-
Executive Retention Bonuses Approved
The Compensation Committee approved retention bonuses for CEO Eric Schlorff and Kevin Chung, a key executive.
-
Total Compensation Package
The bonuses total $425,000, consisting of $340,000 in cash and $85,000 in restricted stock units (RSUs).
-
Staggered Vesting Schedule
Payments and RSU vesting are scheduled in three installments on July 1, 2026, November 1, 2026, and March 1, 2027, contingent on continued employment.
-
Financial Context
These retention bonuses represent a notable expense for a company that recently reported substantial doubt about its ability to continue as a going concern.
Analysis · ICU · Industrial Applications And Services
Amidst 'going concern' warnings, SeaStar Medical is committing significant capital to retain its CEO and another key executive. While these retention bonuses are crucial for leadership stability, they also represent a substantial cash outflow and future dilution through restricted stock units for a company with limited cash runway.
At the time of this filing, ICU was trading at $4.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $19.4M. The 52-week trading range was $2.07 to $12.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.